查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930044

移植市場規模、佔有率、成長及全球產業分析：按類型、應用和地區劃分的洞察與預測（2025-2034）

Transplantation Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 161 Pages | 商品交期: 請詢問到貨日

價格

移植市場成長驅動因素

全球移植市場涵蓋與器官和組織移植相關的醫療程序和產品，包括腎臟、肝臟、心臟、肺臟、角膜、皮膚、骨骼和肌腱。移植在挽救因慢性疾病、創傷、中毒、失血、白血病、敗血症和其他急性疾病導致的器官衰竭患者的生命方面發揮著至關重要的作用。對器官移植手術需求的不斷增長，以及公眾意識的提高和技術創新，正顯著推動市場成長。

市場規模及預測

根據 Fortune Business Insights 的數據，2025 年全球器官移植市場規模為 119.3 億美元。預計到 2026 年將成長至 130.1 億美元，到 2034 年將達到 285.7 億美元，在預測期（2026-2034 年）內，複合年增長率 (CAGR) 為 10.33%。

北美地區在 2025 年將佔市場主導地位，市場佔有率為 42.29%，這得益於其先進的醫療基礎設施、優惠的報銷政策以及眾多的器官捐贈項目。此外，預計到2032年，美國器官移植市場規模將達到85.4億美元，主要得益於器官捐贈率的提高和技術的進步。

市場驅動因素

市場成長的關鍵驅動因素是全球對器官移植需求的不斷增長。癌症、腎衰竭、慢性阻塞性肺病（COPD）和狼瘡等慢性疾病的日益普遍，顯著增加了器官衰竭病例的數量。

例如，根據美國衛生資源與服務管理局（HRSA）的數據，截至2024年2月，美國國家器官移植等待名單上的人數超過10.3萬人。此外，2023年美國進行了超過4.6萬例器官移植手術，凸顯了此類手術的強勁需求。

此外，政府和非政府組織所進行的提高器官捐贈意識的措施也推動了市場擴張。諸如印度器官捐贈組織 (ORGAN India) 和英國國家醫療服務體系 (NHS) 等機構積極開展鼓勵捐贈者登記的活動，從而提高了器官移植率。

新冠疫情的影響

由於擇期手術減少、嚴格的安全指南以及醫院就診量下降，新冠疫情對器官移植市場造成了負面影響，尤其是在 2020 年。全球器官移植手術數量的下降也影響了主要市場參與者的銷售額。

然而，到 2022 年底，隨著醫院恢復運作和器官捐贈意識的提高，市場逐漸復甦。策略研究措施和新產品的推出有助於市場在 2024 年恢復到疫情前的成長軌跡，並支撐了 2025 年至 2032 年的穩定成長。

市場趨勢

影響器官移植市場的關鍵趨勢之一是公共和私營部門利害關係人之間合作的加強。這些合作旨在提高器官捐贈率、加強移植基礎設施建設並簡化供體-受體匹配流程。

例如，移植治療聯盟 (TTC) 透過與產業參與者、學術機構和監管機構合作，加速移植相關領域的創新。同樣，涉及泛美衛生組織 (PAHO) 和西班牙政府等組織的國際合作正在加強各地區的移植生態系統。

成長因素

另一個關鍵的成長因素是組織工程和保存技術的進步。 3D 生物列印、基於幹細胞的組織再生和異種移植等創新技術有助於緩解捐贈者短缺問題並降低排斥風險。

例如，2023 年 6 月，3D BioFibR 公司宣布推出一種用於組織和器官生物列印的新型膠原蛋白基生物墨水產品。這些技術進步拓展了治療的可能性，並支持市場的長期成長。

限制因子

儘管市場成長前景強勁，但器官移植等待時間的延長給市場帶來了挑戰。根據美國捐贈生命組織（Donate Life America）統計，美國平均每八分鐘就有一人被列入器官移植等待名單，腎臟移植的平均等待時間為三至五年。

在發展中國家，認知度低、保險報銷不足以及移植基礎設施匱乏進一步限制了市場成長。這些因素持續阻礙器官移植的廣泛應用。

細分市場分析

  • 依產品類型：免疫抑制劑細分市場佔主導地位，預計到2026年將佔43.18%的市場佔有率，這主要得益於其在預防器官排斥反應方面的重要作用。
  • 按應用領域：組織移植細分市場預計到2026年將佔63.88%的市場佔有率，這主要得益於角膜移植和皮膚移植等手術量的激增。
  • 按最終用戶劃分：醫院在2026年將以60.06%的市場佔有率領先，這主要得益於其作為複雜移植手術主要中心的地位。

區域洞察

北美地區預計在2025年將佔50.4億美元的市場佔有率，憑藉先進的技術和強有力的監管支持，將繼續保持市場領先地位。歐洲將保持其第二大市場佔有率，這得益於教育活動和不斷增長的手術量。亞太地區正經歷快速成長，這主要歸功於慢性病盛行率的上升和醫療基礎設施的改善，尤其是在中國、日本和印度。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家主要器官移植量（2025 年）
  • 主要產業趨勢－併購與合作
  • 監理環境概述
  • 新冠疫情對市場的影響

第五章：全球移植市場分析、洞察與預測（2021-2034）

  • 市場分析、洞察與預測 - 按產品類型劃分
    • 組織產品
    • 免疫抑制劑
    • 保存液
  • 市場分析、洞察與預測 - 按應用劃分
    • 器官移植
    • 組織移植
  • 市場分析、洞察與預測 - 按最終用戶劃分
    • 醫院
    • 移植中心
    • 其他
  • 市場分析、洞察與預測 - 按地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美移植市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲移植市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲國家

第八章 亞太地區移植市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 東南亞亞洲
    • 亞太其他地區

第九章 拉丁美洲移植市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章 中東與非洲移植市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會
    • 南非
    • 其他中東和非洲國家

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 公司型材
    • 諾華公司
    • 梯瓦製藥工業股份有限公司
    • Arthrex 公司
    • Veloxis Pharmaceuticals, Inc.（旭化成株式會社）
    • 生物生命解決方案
    • 跨醫療公司
    • F.霍夫曼-拉羅氏有限公司
    • Zimmer Biomet
    • 安斯泰來藥廠
Product Code: FBI105049

Growth Factors of transplantation Market

The global transplantation market comprises medical procedures and products related to the transplantation of organs and tissues, including kidneys, liver, heart, lungs, cornea, skin, bones, and tendons. Transplantation plays a critical role in saving lives affected by organ failure caused by chronic diseases, trauma, poisoning, blood loss, leukemia, sepsis, and other acute conditions. Rising demand for transplant procedures, coupled with increasing awareness and technological innovation, is significantly driving the market's growth.

Market Size and Forecast

According to Fortune Business Insights, the global transplantation market was valued at USD 11.93 billion in 2025. It is projected to grow to USD 13.01 billion in 2026 and further expand to USD 28.57 billion by 2034, registering a CAGR of 10.33% during the forecast period (2026-2034).

North America dominated the market with a 42.29% share in 2025, supported by advanced healthcare infrastructure, favorable reimbursement policies, and a high number of organ donation programs. Additionally, the U.S. transplantation market is projected to reach USD 8.54 billion by 2032, driven by increasing organ donation rates and technological advancements.

Market Drivers

A key factor driving market growth is the increasing demand for transplantation procedures worldwide. The rising prevalence of chronic conditions such as cancer, kidney failure, chronic obstructive pulmonary disease (COPD), and lupus has significantly increased organ failure cases.

For instance, according to the U.S. Health Resources & Services Administration, over 103,000 individuals were on the U.S. national organ transplant waiting list in February 2024. Furthermore, in 2023, more than 46,000 organ transplant procedures were performed in the U.S., highlighting strong procedural demand.

In addition, government and non-government initiatives promoting organ donation awareness are boosting market expansion. Organizations such as ORGAN India and the National Health Service (NHS) in the U.K. actively run campaigns encouraging donor registration, thereby increasing transplantation rates.

COVID-19 Impact

The COVID-19 pandemic negatively impacted the transplantation market, particularly during 2020, due to reduced elective procedures, strict safety guidelines, and fewer hospital visits. Transplant procedures declined globally, affecting the sales of key market players.

However, the market gradually recovered by the end of 2022, as hospital operations resumed and awareness regarding organ donation increased. Strategic research initiatives and new product launches helped the market return to its pre-pandemic growth trajectory by 2024, supporting stable growth during 2025-2032.

Market Trends

One of the major trends shaping the transplantation market is the increase in collaborations between public and private stakeholders. These collaborations aim to improve organ donation rates, enhance transplant infrastructure, and streamline donor-recipient matching processes.

For example, the Transplant Therapeutics Consortium (TTC) collaborates with industry players, academic institutions, and regulatory agencies to accelerate transplant-related innovations. Similarly, international collaborations involving organizations such as PAHO and the Government of Spain are strengthening transplant ecosystems across regions.

Growth Factors

Another significant growth driver is the advancement in tissue engineering and preservation technologies. Innovations such as 3D bioprinting, stem cell-based tissue regeneration, and xenotransplantation are addressing donor shortages and reducing rejection risks.

For instance, in June 2023, 3D BioFibR launched novel collagen-based bio-ink products for tissue and organ bioprinting. These technological advancements are expanding treatment possibilities and supporting long-term market growth.

Restraining Factors

Despite strong growth prospects, the market faces challenges due to prolonged waiting periods for transplant procedures. According to Donate Life America, one person is added to the U.S. transplant waiting list every 8 minutes, and the average waiting time for kidney transplantation ranges from 3 to 5 years.

In developing countries, limited awareness, inadequate reimbursement policies, and insufficient transplant infrastructure further restrict market growth. These factors continue to act as barriers to widespread adoption.

Segmentation Analysis

  • By Product Type: The immunosuppressive drugs segment dominated the market with a 43.18% share in 2026, owing to their essential role in preventing organ rejection.
  • By Application: The tissue transplantation segment held a 63.88% market share in 2026, driven by the high volume of procedures such as corneal and skin transplants.
  • By End-user: Hospitals led the market with a 60.06% share in 2026, as they remain primary centers for complex transplant procedures.

Regional Insights

North America accounted for USD 5.04 billion in 2025 and continues to dominate due to advanced technologies and strong regulatory support. Europe holds the second-largest share, supported by awareness initiatives and increasing procedures. Asia Pacific is witnessing rapid growth due to rising chronic disease prevalence and improving healthcare infrastructure, particularly in China, Japan, and India.

Competitive Landscape

The market is moderately fragmented, with leading players such as Zimmer Biomet, Astellas Pharma, BioLife Solutions, Novartis AG, TransMedics, and Roche. These companies focus on product innovation, strategic partnerships, and acquisitions to strengthen their market position.

Conclusion

In conclusion, the global transplantation market is expected to grow from USD 11.93 billion in 2025 to USD 28.57 billion by 2034, driven by rising organ failure cases, increasing transplant procedures, supportive government initiatives, and continuous technological advancements. While challenges such as donor shortages and long waiting periods persist, expanding awareness programs, innovation in tissue engineering, and strong collaboration among stakeholders are expected to sustain robust market growth throughout the forecast period.

Segmentation By Product Type

  • Tissue Products
  • Immunosuppressive Drugs
  • Preservation Solutions

By Application

  • Organ Transplantation
  • Tissue Transplantation

By End-user

  • Hospitals
  • Transplantation Centers
  • Others

By Region

  • North America (By Product Type, Application, End-user, and Country/Sub-Region)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Product Type, Application, End-user, and Country/Sub-Region)
    • Germany (By Application)
    • France (By Application)
    • U.K. (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Product Type, Application, End-user, and Country/Sub-Region)
    • China (By Application)
    • Japan (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Product Type, Application, End-user, and Country/Sub-Region)
    • Brazil (By Application)
    • Mexico (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Product Type, Application, End-user, and Country/Sub-Region)
    • GCC (By Application)
    • South Africa (By Application)
    • Rest of the Middle East & Africa (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Major Organ Transplantation, By Key Countries, 2025
  • 4.2. Key Industry Developments- Mergers, Acquisitions and Partnerships
  • 4.3. Overview of Regulatory Scenario
  • 4.4. Impact of COVID-19 on the Market

5. Global Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Tissue Products
    • 5.1.2. Immunosuppressive Drugs
    • 5.1.3. Preservation Solutions
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Organ Transplantation
    • 5.2.2. Tissue Transplantation
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Transplantation Centers
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Tissue Products
    • 6.1.2. Immunosuppressive Drugs
    • 6.1.3. Preservation Solutions
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Organ Transplantation
    • 6.2.2. Tissue Transplantation
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Transplantation Centers
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
    • 6.4.2. Canada
      • 6.4.2.1. By Application

7. Europe Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Tissue Products
    • 7.1.2. Immunosuppressive Drugs
    • 7.1.3. Preservation Solutions
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Organ Transplantation
    • 7.2.2. Tissue Transplantation
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Transplantation Centers
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
      • 7.4.1.1. By Application
    • 7.4.2. France
      • 7.4.2.1. By Application
    • 7.4.3. U.K.
      • 7.4.3.1. By Application
    • 7.4.4. Italy
      • 7.4.4.1. By Application
    • 7.4.5. Spain
      • 7.4.5.1. By Application
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Application
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Application

8. Asia Pacific Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Tissue Products
    • 8.1.2. Immunosuppressive Drugs
    • 8.1.3. Preservation Solutions
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Organ Transplantation
    • 8.2.2. Tissue Transplantation
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Transplantation Centers
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. China
      • 8.4.1.1. By Application
    • 8.4.2. Japan
      • 8.4.2.1. By Application
    • 8.4.3. India
      • 8.4.3.1. By Application
    • 8.4.4. Australia
      • 8.4.4.1. By Application
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Application
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Application

9. Latin America Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Tissue Products
    • 9.1.2. Immunosuppressive Drugs
    • 9.1.3. Preservation Solutions
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Organ Transplantation
    • 9.2.2. Tissue Transplantation
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Transplantation Centers
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
      • 9.4.1.1. By Application
    • 9.4.2. Mexico
      • 9.4.2.1. By Application
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Application

10. Middle East & Africa Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Tissue Products
    • 10.1.2. Immunosuppressive Drugs
    • 10.1.3. Preservation Solutions
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Organ Transplantation
    • 10.2.2. Tissue Transplantation
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Transplantation Centers
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
      • 10.4.1.1. By Application
    • 10.4.2. South Africa
      • 10.4.2.1. By Application
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Application

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Novartis AG
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Teva Pharmaceutical Industries Ltd.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Arthrex, Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Veloxis Pharmaceuticals, Inc. (Asahi Kasei Corporation)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. BioLife Solutions
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. TransMedics
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. F. Hoffmann-La Roche Ltd
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Zimmer Biomet
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Astellas Pharma Inc.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 02: Global Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 03: Global Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 04: Global Transplantation Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 05: North America Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 06: North America Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 07: North America Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 08: North America Transplantation Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 09: U.S. Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 10: Canada Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 11: Europe Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 12: Europe Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 13: Europe Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 14: Europe Transplantation Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 15: Germany Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 16: France Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 17: U.K. Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 18: Italy Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Spain Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 20: Scandinavia Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 21: Rest of Europe Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 22: Asia Pacific Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 23: Asia Pacific Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 24: Asia Pacific Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 25: Asia Pacific Transplantation Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 26: China Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 27: Japan Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 28: India Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 29: Australia Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 30: Southeast Asia Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 31: Rest of Asia-Pacific Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 32: Latin America Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 33: Latin America Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 34: Latin America Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 35: Latin America Transplantation Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 36: Brazil Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 37: Mexico Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 38: Rest of Latin America Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 39: Middle East & Africa Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 40: Middle East & Africa Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 41: Middle East & Africa Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 42: Middle East & Africa Transplantation Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 43: GCC Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 44: South Africa Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 45: Rest of Middle East & Africa Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034

List of Figures

  • Figure 01: Global Transplantation Market Revenue Breakdown (USD billion, %) By Region, 2025 & 2034
  • Figure 02: Global Transplantation Market Value Share (%), By Product Type, 2025 & 2034
  • Figure 03: Global Transplantation Market Value Share (%), By Application, 2025 & 2034
  • Figure 04: Global Transplantation Market Value Share (%), By End-user, 2025 & 2034
  • Figure 05: Global Transplantation Market Value Share (%), By Region, 2025 & 2034
  • Figure 06: North America Transplantation Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 07: North America Transplantation Market Value Share (%), By Product Type, 2025
  • Figure 08: North America Transplantation Market Value (USD billion), By Application, 2025 & 2034
  • Figure 09: North America Transplantation Market Value Share (%), By Application, 2025
  • Figure 10: North America Transplantation Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 11: North America Transplantation Market Value Share (%), By End-user, 2025
  • Figure 12: North America Transplantation Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Transplantation Market Value Share (%), By Country, 2025
  • Figure 14: Europe Transplantation Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 15: Europe Transplantation Market Value Share (%), By Product Type, 2025
  • Figure 16: Europe Transplantation Market Value (USD billion), By Application, 2025 & 2034
  • Figure 17: Europe Transplantation Market Value Share (%), By Application, 2025
  • Figure 18: Europe Transplantation Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 19: Europe Transplantation Market Value Share (%), By End-user, 2025
  • Figure 20: Europe Transplantation Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 21: Europe Transplantation Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 22: Asia Pacific Transplantation Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Transplantation Market Value Share (%), By Product Type, 2025
  • Figure 24: Asia Pacific Transplantation Market Value (USD billion), By Application, 2025 & 2034
  • Figure 25: Asia Pacific Transplantation Market Value Share (%), By Application, 2025
  • Figure 26: Asia Pacific Transplantation Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 27: Asia Pacific Transplantation Market Value Share (%), By End-user, 2025
  • Figure 28: Asia Pacific Transplantation Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 29: Asia Pacific Transplantation Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 30: Latin America Transplantation Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 31: Latin America Transplantation Market Value Share (%), By Product Type, 2025
  • Figure 32: Latin America Transplantation Market Value (USD billion), By Application, 2025 & 2034
  • Figure 33: Latin America Transplantation Market Value Share (%), By Application, 2025
  • Figure 34: Latin America Transplantation Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 35: Latin America Transplantation Market Value Share (%), By End-user, 2025
  • Figure 36: Latin America Transplantation Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 37: Latin America Transplantation Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 38: Middle East & Africa Transplantation Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 39: Middle East & Africa Transplantation Market Value Share (%), By Product Type, 2025
  • Figure 40: Middle East & Africa Transplantation Market Value (USD billion), By Application, 2025 & 2034
  • Figure 41: Middle East & Africa Transplantation Market Value Share (%), By Application, 2025
  • Figure 42: Middle East & Africa Transplantation Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Transplantation Market Value Share (%), By End-user, 2025
  • Figure 44: Middle East & Africa Transplantation Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 45: Middle East & Africa Transplantation Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 46: Global Transplantation Market Share Analysi (%), By Company, 2025